Serial Number 98160020
730

Registration Progress

Application Filed
Aug 31, 2023
Under Examination
Oct 22, 2024
Approved for Publication
Aug 27, 2024
Published for Opposition
Aug 27, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Oct 22, 2025 91 days

Trademark Image

Basic Information

Serial Number
98160020
Filing Date
August 31, 2023
Published for Opposition
August 27, 2024
Drawing Code
2

Status Summary

Current Status
Active
Status Code
730
Status Date
Apr 14, 2025
Application
Pending
Classes
005 042

Rights Holder

Iolyx Therapeutics, Inc.

03
Address
1325 Howard Ave, #904
Burlingame, CA 94010

Ownership History

Iolyx Therapeutics, Inc.

Original Applicant
03
Burlingame, CA

Iolyx Therapeutics, Inc.

Owner at Publication
03
Burlingame, CA

Legal Representation

Attorney
Susan Piascik Christoff

USPTO Deadlines

Next Deadline
91 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
October 22, 2025
Extension Available
Until October 22, 2025

Application History

26 events
Date Code Type Description Documents
Apr 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 14, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 14, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 14, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 22, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 27, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 27, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 19, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 19, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 19, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Aug 7, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 24, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 24, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 24, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 24, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 28, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 28, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 28, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jun 28, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 29, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 29, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 29, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 29, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 28, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 27, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 4, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals and pharmaceutical preparations all for use in the prevention and treatment of ophthalmological, immunological, and inflammatory diseases and disorders
Class 042
Pharmaceutical research and development services; scientific and medical research services in the field of pharmaceutical development; scientific and medical information services in the field of pharmaceutical development, namely, providing information about medical and scientific research related to development of pharmaceuticals

Additional Information

Design Mark
The mark consists of an abstract six pointed star in ombre shades of pink, violet and blue with the opposite points forming almond shapes and in the center of which is a shaded blue circle with a highlight crescent at the upper right of the circle, resembling an eye. The color white represents background, outlining, shading, and/or transparent area and is not part of the mark.
Color Claim
The color(s) pink, violet, and blue is/are claimed as a feature of the mark.

Classification

International Classes
005 042